| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |